CTRI/2021/05/033790已完成未知
A randomized, double blind, placebo controlled, multi-centric, trial to determine the therapeutic efficacy of Ayush medicine NOQ19 in treatment of symptomatic COVID-19 patients along with standard allopathic treatment
Sriveda Sattva Private Limited Sri Sri Tattva0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Symptomatic COVID 19 infection with or without comorbidities
- •Willingness to participate in the study
- •Indian nationals
排除标准
- •Age less than 18 years or more than 75 years
- •Pregnancy and Lactation
- •Patient not willing to participate in the study
研究者
相似试验
进行中（未招募）
不适用
A study comparing bevacizumab with placebo when added to the current standard of treatment (temozolomide and radiotherapy, followed by temozolomide) in patients with a type of newly diagnosed brain tumor named GlioblastomaMedDRA version: 14.1Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)GlioblastomaEUCTR2008-006146-26-NLF. Hoffmann-La Roche Ltd921
进行中（未招募）
不适用
A study comparing bevacizumab with placebo when added to the current standard of treatment (temozolomide and radiotherapy, followed by temozolomide) in patients with a type of newly diagnosed brain tumor named GlioblastomaMedDRA version: 15.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)GlioblastomaEUCTR2008-006146-26-DKF. Hoffmann-La Roche Ltd921
已完成
不适用
To assess the effectiveness of study medication LactoSporein comparison with Placeboi.e. a substance with no effect in patients suffering from Major Depressive Disorder in Inflammatory Bowel Syndrome.CTRI/2015/05/005754Sami labs Limited40
进行中（未招募）
不适用
A randomized, double blind, placebo controlled, multicenter study to determine the effect of QVA149 on mean 24-hours heart rate in patients with Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary DiseaseMedDRA version: 9.1Level: LLTClassification code 10009033Term: Chronic obstructive pulmonary diseaseEUCTR2007-003670-25-FRovartis Pharma AG250
进行中（未招募）
不适用
A study comparing bevacizumab with placebo when added to the current standard of treatment (temozolomide and radiotherapy, followed by temozolomide) in patients with a type of newly diagnosed brain tumor named GlioblastomaMedDRA version: 17.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)GlioblastomaEUCTR2008-006146-26-DEF. Hoffmann-La Roche Ltd921